If you are experiencing bloating, constipation, or ongoing digestive discomfort while on GLP-1 therapy, understand that these symptoms are not something you just have to endure
Verified Customer IMPORTANT NOTICE These products are intended strictly for laboratory and research purposes only
Youll lift weights while nauseated
Questions about "retatrutide dosage" are common because its Phase 2 obesity results were striking, but the only dosing information that exists for this compound comes from clinical trials, not an approved label
Retatrutide, on the other hand, is a newer investigational agent described as a triple-agonist (targeting GLP-1, GIP, and glucagon receptors) and has demonstrated promising early data for greater weight reduction and fat-burning potential
Editors note: An earlier version of this article was first published on July 3, 2023